Related Experiment Video

Updated: Jun 8, 2026

Histological Quantification of Chronic Myocardial Infarct in Rats
09:45

Histological Quantification of Chronic Myocardial Infarct in Rats

Published on: December 11, 2016

The relationship between admission hemoglobin level and left ventricular systolic functions in patients with first

Nihat Sen1, Hüseyin Uğur Yazici, Yusuf Tavil

  • 1Department of Cardiology, Medicine Faculty of Gazi University, Ankara, Turkey.

Turk Kardiyoloji Dernegi Arsivi : Turk Kardiyoloji Derneginin Yayin Organidir
|October 12, 2010
PubMed

Insights

Mild anemia does not impair systolic function in patients experiencing their first ST-segment elevated myocardial infarction (STEMI). This study found no significant negative impact of anemia on key cardiac measures in STEMI patients.

Area of Science:

  • Cardiology
  • Internal Medicine
  • Hematology

Background:

  • ST-segment elevated myocardial infarction (STEMI) is a critical cardiovascular event.
  • Hemoglobin levels and anemia are common in acute illness, potentially affecting cardiac function.
  • The impact of anemia on left ventricular systolic function post-STEMI requires clarification.

Purpose of the Study:

  • To investigate the association between admission hemoglobin levels and left ventricular systolic function in patients with their first STEMI.
  • To compare echocardiographic parameters in STEMI patients with and without anemia.

Main Methods:

  • Prospective study of 483 patients with first STEMI across three centers.
  • Echocardiography performed to assess ejection fraction (EF), wall motion score index (WMSI), and tissue Doppler S wave velocities.
  • Hemoglobin levels measured on admission; anemia defined by WHO criteria.

Main Results:

  • Anemia was present in 13.9% of STEMI patients.
  • No significant differences in EF or WMSI between anemic and non-anemic groups.
  • Septal mitral annular S wave velocity was significantly lower in anemic patients, but overall correlation between hemoglobin and EF was not significant.

Conclusions:

  • Mild to moderate anemia does not appear to have a deleterious effect on overall left ventricular systolic function in patients with first STEMI.
  • Further research may explore specific regional myocardial function impacts.
Abstract

More Related Videos

Myocardial Infarction and Functional Outcome Assessment in Pigs12:03

Myocardial Infarction and Functional Outcome Assessment in Pigs

Published on: April 25, 2014

Related Concept Videos

Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...